CBER “Critical Path” workshop
FDA schedules public workshop on the development of biological products for Oct. 7. The meeting will take place at the Marriott Washingtonian Center in Gaithersburg, Md. from 8:30 a.m. to 5 p.m....
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."